Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
1162 | 2712 | 47.9 | 94% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | TRAIL | Author keyword | 805 | 54% | 38% | 1032 |
2 | DR5 | Author keyword | 101 | 59% | 4% | 114 |
3 | TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND | Author keyword | 92 | 63% | 3% | 92 |
4 | TNF RELATED APOPTOSIS INDUCING LIGAND | Author keyword | 59 | 65% | 2% | 57 |
5 | DEATH RECEPTOR 5 | Author keyword | 59 | 71% | 2% | 48 |
6 | TRAIL RECEPTORS | Author keyword | 58 | 86% | 1% | 30 |
7 | DR4 | Author keyword | 53 | 62% | 2% | 55 |
8 | TRAIL RECEPTOR | Author keyword | 50 | 84% | 1% | 27 |
9 | TRAIL RESISTANCE | Author keyword | 44 | 85% | 1% | 23 |
10 | APO2L TRAIL | Author keyword | 42 | 70% | 1% | 35 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | TRAIL | 805 | 54% | 38% | 1032 | Search TRAIL | Search TRAIL |
2 | DR5 | 101 | 59% | 4% | 114 | Search DR5 | Search DR5 |
3 | TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND | 92 | 63% | 3% | 92 | Search TUMOR+NECROSIS+FACTOR+RELATED+APOPTOSIS+INDUCING+LIGAND | Search TUMOR+NECROSIS+FACTOR+RELATED+APOPTOSIS+INDUCING+LIGAND |
4 | TNF RELATED APOPTOSIS INDUCING LIGAND | 59 | 65% | 2% | 57 | Search TNF+RELATED+APOPTOSIS+INDUCING+LIGAND | Search TNF+RELATED+APOPTOSIS+INDUCING+LIGAND |
5 | DEATH RECEPTOR 5 | 59 | 71% | 2% | 48 | Search DEATH+RECEPTOR+5 | Search DEATH+RECEPTOR+5 |
6 | TRAIL RECEPTORS | 58 | 86% | 1% | 30 | Search TRAIL+RECEPTORS | Search TRAIL+RECEPTORS |
7 | DR4 | 53 | 62% | 2% | 55 | Search DR4 | Search DR4 |
8 | TRAIL RECEPTOR | 50 | 84% | 1% | 27 | Search TRAIL+RECEPTOR | Search TRAIL+RECEPTOR |
9 | TRAIL RESISTANCE | 44 | 85% | 1% | 23 | Search TRAIL+RESISTANCE | Search TRAIL+RESISTANCE |
10 | APO2L TRAIL | 42 | 70% | 1% | 35 | Search APO2L+TRAIL | Search APO2L+TRAIL |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DECOY RECEPTORS | 405 | 75% | 11% | 296 |
2 | APOPTOSIS INDUCING LIGAND | 344 | 42% | 23% | 631 |
3 | TRAIL INDUCED APOPTOSIS | 253 | 39% | 19% | 513 |
4 | APO2L TRAIL | 208 | 80% | 5% | 129 |
5 | LIGAND TRAIL | 189 | 56% | 9% | 231 |
6 | FADD DEPENDENT APOPTOSIS | 179 | 73% | 5% | 136 |
7 | CYTOTOXIC LIGAND TRAIL | 125 | 66% | 4% | 117 |
8 | DEATH RECEPTORS | 118 | 37% | 10% | 258 |
9 | DEATH RECEPTOR 5 | 112 | 75% | 3% | 81 |
10 | APO2 LIGAND | 111 | 80% | 3% | 70 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
On the TRAIL to successful cancer therapy? Predicting and counteracting resistance against TRAIL-based therapeutics | 2013 | 61 | 93 | 73% |
Targeting extrinsic apoptosis in cancer: Challenges and opportunities | 2015 | 3 | 81 | 62% |
The TRAIL apoptotic pathway in cancer onset, progression and therapy | 2008 | 391 | 194 | 73% |
Targeting apoptosis for anticancer therapy | 2015 | 5 | 57 | 35% |
Getting TRAIL back on track for cancer therapy | 2014 | 24 | 152 | 51% |
Ligand-based targeting of apoptosis in cancer: The potential of recombinant human apoptosis ligand 2/tumor necrosis factor-related apoptosis-inducing ligand (rhApo2L/TRAIL) | 2008 | 222 | 67 | 81% |
TRAIL Signaling and Synergy Mechanisms Used in TRAIL-Based Combination Therapies | 2012 | 50 | 71 | 77% |
TRAIL receptor signalling and modulation: Are we on the right TRAIL? | 2009 | 122 | 124 | 81% |
Apo2L/TRAIL and its death and decoy receptors | 2003 | 536 | 101 | 74% |
Death receptors as targets in cancer | 2013 | 29 | 133 | 78% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | OPTOSIS REGULAT | 13 | 44% | 0.8% | 23 |
2 | CELL SIGNALING OPTOSIS | 13 | 62% | 0.5% | 13 |
3 | HUMAN GENE THER Y UNIT | 10 | 54% | 0.5% | 13 |
4 | MORPHOL EMBRYOL | 10 | 17% | 2.0% | 54 |
5 | HUMAN NORMAL MORPHOL | 9 | 67% | 0.3% | 8 |
6 | MOL ONCOL CELL CYCLE REGULAT GENET | 7 | 67% | 0.2% | 6 |
7 | SURG PHARMACOL | 6 | 31% | 0.6% | 17 |
8 | PROGRAM GENE THER Y VIROL | 6 | 50% | 0.3% | 9 |
9 | MOL TARGETING CANC PREVENT | 6 | 19% | 1.0% | 26 |
10 | TRANSLAT ONCOL EXPT CANC THER EUT | 5 | 37% | 0.4% | 11 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000141240 | NECROPTOSIS//RIP3//NECROSTATIN 1 |
2 | 0.0000102156 | CASP10//CASP8//CASPASE 10 |
3 | 0.0000091959 | LIVIN//XIAP//SMAC MIMETICS |
4 | 0.0000081671 | OSTEOPROTEGERIN//VASC MED ATHEROTHROMBOSIS//INTERDEPARTMENTAL REGENERAT MED |
5 | 0.0000069570 | TUMOR TROPISM//MOL NEUROTHER Y IMAGING//VET BIOCHEM IMMUNOL |
6 | 0.0000068216 | FAS//FAS LIGAND//AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME |
7 | 0.0000060230 | BIKDD//MITOCHONDRIAL CYTOCHROME C RELEASE//BAX OVEREXPRESSION |
8 | 0.0000057844 | DCR3//DECOY RECEPTOR 3//TL1A |
9 | 0.0000056470 | PHARMACEUT PROTE//PRE LIGAND BINDING ASSEMBLY DOMAIN PLAD//TUMOR NECROSIS FACTOR RECEPTOR TNFR |
10 | 0.0000050285 | SFAS APO 1//ACUTE RELAPSE//AMYLOID PEPTIDE A BETA |